University of California Los Angeles grants BioTime exclusive, worldwide rights to growth factors for stroke recovery delivered with BioTime's HyStem hydrogel technology

University of California Los Angeles

U.S. / Academic

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

BioTime Inc.

U.S. / Tools, Services, and Manufacturing

$194.0m on 04/19/2013 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced